TCL Archive DeVita Alert Advises That Negative Node Breast Cancer Patients Do Better With Adjuvant Therapy May 27, 1988
TCL Archive FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint. July 21, 2006
TCL Archive NCI Staff Recommends Moving Cooperative Groups Into DCT, Increase Funding, Switch Emphasis July 4, 1975